Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Optase

Last content change checked dailysee data sync status

Active ingredient
Glycerin 0.25 mg/1 mL
Other brand names
Drug class
Non-Standardized Chemical Allergen
Dosage form
Solution/ Drops
Route
Ophthalmic
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2023
Label revision date
January 30, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Glycerin 0.25 mg/1 mL
Other brand names
Drug class
Non-Standardized Chemical Allergen
Dosage form
Solution/ Drops
Route
Ophthalmic
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2023
Label revision date
January 30, 2026
Manufacturer
Scope Health Inc
Registration number
M018
NDC root
72972-005
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Optase Hylo Relief is a lubricant designed to help relieve dryness in the eyes. It works by providing moisture and protection to the eye surface, which can help prevent further irritation. This product is particularly useful for individuals experiencing discomfort due to dry eyes, offering soothing relief and a protective barrier against environmental factors that may cause irritation.

Uses

You can use this product as a lubricant to help prevent further irritation, making it a great option if you're experiencing discomfort. It also acts as a protectant, shielding your eyes from additional irritation. If you're dealing with dryness in your eyes, this product is designed to provide relief and restore comfort.

Rest assured, there are no concerns regarding teratogenic effects (which are harmful effects on a developing fetus) or nonteratogenic effects associated with this product.

Dosage and Administration

When you need to relieve discomfort in your eyes, simply put one or two drops of the medication directly into the affected eye. You can do this as needed, depending on how your eyes feel. Make sure to follow any specific instructions provided by your healthcare provider for the best results.

What to Avoid

It's important to keep this medication out of reach of children to prevent accidental ingestion. If you or someone else swallows it, seek medical help immediately or contact a poison control center for assistance.

Currently, there are no specific contraindications, controlled substance classifications, or noted risks of abuse, misuse, or dependence associated with this medication. However, always use it responsibly and follow any additional guidance from your healthcare provider.

Side Effects

It's important to use this medication only on the outside of your body. If the solution changes color or becomes cloudy, you should not use it.

You should stop using the product and consult your doctor if you experience any eye pain, notice changes in your vision, or if you have redness or irritation in your eye that persists. Additionally, if your condition worsens or does not improve within 72 hours, seek medical advice.

Warnings and Precautions

This product is for external use only, so please avoid ingesting it. If you notice that the solution changes color or becomes cloudy, do not use it.

You should stop using this product and contact your doctor if you experience any eye pain, notice changes in your vision, or if redness or irritation in your eye persists. Additionally, if your condition worsens or does not improve within 72 hours, it's important to seek medical advice.

In case of accidental swallowing, seek emergency medical help or contact a poison control center immediately. Your safety is a priority, so please take these precautions seriously.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.

In case of an overdose, you should contact your local emergency services or go to the nearest hospital right away. Always keep the medication packaging on hand, as it can provide important information to healthcare professionals. Remember, it's better to be safe and get checked out if you have any concerns about an overdose.

Pregnancy Use

When considering the use of OPTASE glycerin solution or drops during pregnancy, it's important to note that there is no specific information available about its safety, dosage adjustments, or any special precautions for pregnant individuals. This means that the effects of this product on pregnancy have not been studied or documented.

If you are pregnant or planning to become pregnant, it is always best to consult with your healthcare provider before using any medication, including over-the-counter products like OPTASE. They can provide personalized advice and help you weigh the potential risks and benefits.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or considerations mentioned regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. Always consult with your healthcare provider if you have any concerns or questions about your specific situation.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If your child swallows any of it, seek medical help immediately or contact a poison control center for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. If you or a loved one is an older adult, it’s wise to discuss any potential risks or benefits with your healthcare provider. They can help determine the best course of action based on individual health needs and any other medications being taken.

Always keep in mind that older adults may have different responses to medications, so regular check-ins with your doctor can ensure safety and effectiveness.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

It's always best to discuss your individual situation with your healthcare provider, who can offer personalized advice and ensure that any medications you take are safe and effective for you.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not change based on liver impairment. However, it’s always a good idea to discuss your liver health with your healthcare provider, as they can offer personalized advice and monitor your condition appropriately.

Make sure to keep your doctor informed about any liver issues you may have, as they can help ensure that your treatment is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any lab tests you may be undergoing. This way, you can receive the best possible care tailored to your needs.

Storage and Handling

You can feel confident that there are no specific storage, handling, or disposal instructions for this product or device. This means you can use it as intended without worrying about special requirements. Always ensure that you handle it with care to maintain its integrity and effectiveness. If you have any questions or concerns about its use, don't hesitate to reach out for more information.

Additional Information

No further information is available.

FAQ

What is Optase Hylo Relief used for?

Optase Hylo Relief is used as a lubricant to relieve dryness of the eye and to prevent further irritation.

How should I use Optase Hylo Relief?

You should put one or two drops in the affected eyes as needed.

Are there any contraindications for using Optase Hylo Relief?

There are no contraindications listed for Optase Hylo Relief.

What should I do if I experience eye pain or changes in vision?

You should stop using Optase Hylo Relief and ask your doctor if you feel eye pain, experience changes in vision, or if redness or irritation lasts.

Is Optase Hylo Relief safe to use during pregnancy?

There is no specific information regarding the use of Optase Hylo Relief during pregnancy.

What should I do if I accidentally swallow Optase Hylo Relief?

If swallowed, you should get medical help or contact a poison control center right away.

Are there any warnings associated with Optase Hylo Relief?

Yes, it is for external use only, and you should not use it if the solution changes color or becomes cloudy.

How should I store Optase Hylo Relief?

No specific storage instructions are provided for Optase Hylo Relief.

Packaging Info

Below are the non-prescription pack sizes of Optase (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Optase.
Details

Drug Information (PDF)

This file contains official product information for Optase, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use as a lubricant to prevent further irritation of the eye. It may also be utilized as a protectant against additional irritation and is effective in relieving dryness of the eye.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to administer one to two drops of the medication into the affected eyes as needed. It is important to ensure that the dropper does not come into contact with the eye or any other surface to maintain sterility. The frequency of administration should be determined based on the patient's condition and response to treatment.

Contraindications

Use of this product is contraindicated in the following situations:

  • The product should be kept out of reach of children to prevent accidental ingestion.

  • In the event of accidental swallowing, immediate medical assistance or contact with a poison control center is required.

Warnings and Precautions

For external use only. The solution should not be used if it changes color or becomes cloudy, as this may indicate a compromised product.

Patients should be advised to discontinue use and consult a healthcare professional if they experience any of the following: eye pain, changes in vision, persistent redness or irritation of the eye, or if their condition worsens or does not improve within 72 hours.

In the event of accidental ingestion, immediate medical assistance should be sought, or the individual should contact a poison control center without delay.

Side Effects

Patients should be aware that the product is intended for external use only. It is crucial to discontinue use and consult a healthcare professional if any of the following occur: eye pain, changes in vision, persistent redness or irritation of the eye, or if the condition worsens or lasts longer than 72 hours.

Additionally, if the solution changes color or becomes cloudy, it should not be used. These precautions are essential to ensure the safety and well-being of patients using the product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Optase (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Optase.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of OPTASE glycerin solution/drops during pregnancy. Consequently, the safety of this medication in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when prescribing this medication to women of childbearing potential and weigh the potential risks and benefits.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns. However, as with any medication, it is advisable to monitor breastfed infants for any potential effects.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential. If symptoms of overdosage are observed, appropriate interventions should be implemented based on the patient's condition.

Healthcare professionals should also consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the specific situation. Documentation of the incident and any interventions performed is crucial for ongoing patient care and safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a poison control center immediately. This information is crucial for ensuring the safety and well-being of both patients and their families.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. There are no specific storage, handling, or disposal instructions provided. Therefore, standard storage practices should be followed to ensure the integrity of the product. It is advisable to store the product in a cool, dry place, away from direct sunlight and extreme temperatures.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Optase, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Optase, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.